Revance Therapeutics Inc (RVNC) Inventory Turnover Ratio, from third quarter 2024 to third quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Revance Therapeutics Inc   (NASDAQ: RVNC)
 

Revance Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2024, Revance Therapeutics Inc 's inventory turnover ratio sequentially decreased to 1.05 in the third quarter 2024, unsurprisingly, as the Revance Therapeutics Inc markets continue to deteriorate, and RVNC's faces growing challenges to bring down its inventories. Revance Therapeutics Inc 's average inventory processing period in the Sep 30 2024 quarter, has increased to 348 days, from 297 days, in the Jun 30 2024 quarter.

Within Healthcare sector 340 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1173 in the second quarter 2024, to 1238.

RVNC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Revance Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RVNC Inventory Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Inventory Growth 84.39 % 98.23 % 81.03 % 148.73 % 169.03 %
Y / Y Cost of Sales Growth 4.83 % 0.16 % 19.41 % 22.65 % 93.77 %
Inventory Turnover Ratio (TTM) 1.05 1.23 1.47 1.62 1.88
RVNC's Total Ranking # 1238 # 1173 # 1173 # 946 # 946
Average inventory processing period 347 296 249 225 194
Seq. Inventory Growth 24.79 % 35.81 % 10.31 % -1.37 % 34.16 %
Seq. Cost of Sales Growth -0.01 % 18.27 % -3.3 % -8.33 % -4.46 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 104
Healthcare Sector # 341
Overall Market # 1238

Inventory Turnover Ratio Statistics
High Average Low
4.78 2.89 1.05
(Dec 31 2021)   (Sep 30 2024)



RVNC Company Profile >> Back to RVNC Efficiency Comparisons >> Compare RVNC Inventory Turnover Ratio to its Competitors

Financial Statements
Revance Therapeutics Inc 's Inventories $ 85 Millions Visit RVNC's Balance sheet
Revance Therapeutics Inc 's Cost of Revenues TTM $ 66 Millions Visit RVNC's Income Statement
What are RVNC's Sales? Visit RVNC's Sales by Segment

Other Inventory Turnover Ratios
Revance Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RVNC's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RVNC's Competitors
Inventory Turnover Ratio for RVNC's Suppliers
Inventory Turnover Ratio for RVNC's Customers

You may also want to know
RVNC's Sales Growth Rates RVNC's Pe Price to earnings ratio RVNC's Receivables Turnover Ratio RVNC's Stock Quote
RVNC's Net Income Growth Rates RVNC's Ps Price to Sales ratio RVNC's Sales per Employee RVNC's Asset Turnover Ratio
RVNC's Net Margin RVNC's Pb Price to Book ratio RVNC's Financial Strength Ratios RVNC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2024 Inventories at quarter ending Sep 30 2024
Teleflex Incorporated  2.10 $ 1,330.448  Millions$ 633  Millions
Journey Medical Corp  2.10 $ 22.215  Millions$ 11  Millions
Pacific Biosciences Of California Inc   2.09 $ 134.861  Millions$ 65  Millions
Coherus Oncology inc   2.08 $ 90.544  Millions$ 43  Millions
Lifecore Biomedical Inc   2.07 $ 83.989  Millions$ 41  Millions
Rxsight Inc   2.07 $ 39.877  Millions$ 19  Millions
Intelligent Bio Solutions Inc   2.06 $ 1.736  Millions$ 1  Millions
Accuray Incorporated  2.04 $ 305.451  Millions$ 149  Millions
Edap Tms Sa  2.04 $ 40.333  Millions$ 20  Millions
Organon and Co   2.04 $ 2,675.000  Millions$ 1,312  Millions
Skinhealth Systems Inc   2.04 $ 171.826  Millions$ 84  Millions
Sonendo Inc   2.03 $ 23.622  Millions$ 12  Millions
Cerus Corporation  2.03 $ 77.313  Millions$ 38  Millions
Bioventus Inc   2.01 $ 184.000  Millions$ 91  Millions
Axsome Therapeutics Inc   2.00 $ 30.167  Millions$ 15  Millions
Nature s Sunshine Products inc   2.00 $ 127.308  Millions$ 64  Millions
Innovative Eyewear Inc   2.00 $ 1.620  Millions$ 1  Millions
Johnson and Johnson  2.00 $ 23,683.000  Millions$ 11,834  Millions
Orthofix Medical Inc   1.97 $ 252.291  Millions$ 128  Millions
Apyx Medical Corp  1.94 $ 18.431  Millions$ 10  Millions
Haemonetics Corporation  1.94 $ 645.000  Millions$ 333  Millions
Intuitive Surgical Inc   1.93 $ 2,596.800  Millions$ 1,346  Millions
Tvardi Therapeutics Inc   1.91 $ 3.737  Millions$ 2  Millions
Boston Scientific Corporation  1.90 $ 4,937.000  Millions$ 2,602  Millions
Procept Biorobotics Corporation  1.89 $ 83.412  Millions$ 44  Millions
Staar Surgical Co  1.89 $ 72.565  Millions$ 38  Millions
Utah Medical Products Inc  1.88 $ 17.382  Millions$ 9  Millions
Ultragenyx Pharmaceutical Inc   1.88 $ 71.885  Millions$ 38  Millions
Beyond Air Inc   1.83 $ 3.746  Millions$ 2  Millions
Yunhong Green Cti Ltd   1.83 $ 14.076  Millions$ 8  Millions

Date modified: 2026-08-29T17:18:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.